Host: |
Rabbit |
Applications: |
WB/IF |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-THADA (1684-1953) is suitable for use in Western Blot and Immunofluorescence research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IF/ICC 1:50-1:100 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
THADA |
Gene ID: |
63892 |
Uniprot ID: |
THADA_HUMAN |
Immunogen Region: |
1684-1953 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1684-1953 of human THADA (NP_071348.3). |
Immunogen Sequence: |
QLVILSCEDHLPTESRLAVV EVLTSTTPLFLTNPHPILEL QDTLALWKCVLTLLQSEEQA VRDAATETVTTAMSQENTCQ STEFAFCQVDASIALALALA VLCDLLQQWDQLAPGLPILL GWLLGESDDLVACVESMHQV EEDYLFEKAEVNFWAETLIF VKYLCKHLFCLLSKSGWRPP SPEMLCHLQRMVSEQCHLLS QFFRELPPAAEFVKTVEFTR LRIQEERTLACLRLLAFLE |
Tissue Specificity | Expressed in pancreas, adrenal medulla, thyroid, adrenal cortex, testis, thymus, small intestine and stomach. |
Function | Together with methyltransferase FTSJ1, methylates the 2'-O-ribose of nucleotides at position 32 of the anticodon loop of substrate tRNAs. |
Protein Name | Trna32-2'-O-Methyltransferase Regulator ThadaGene Inducing Thyroid Adenomas ProteinThyroid Adenoma-Associated Protein |
Database Links | Reactome: R-HSA-6782315 |
Alternative Antibody Names | Anti-Trna antibodyAnti-32-2'-O-Methyltransferase Regulator Thada antibodyAnti-Gene Inducing Thyroid Adenomas Protein antibodyAnti-Thyroid Adenoma-Associated Protein antibodyAnti-THADA antibodyAnti-GITA antibodyAnti-KIAA1767 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance